Gustave Roussy Implements GrayOS for Enhanced Radiation Therapy Management

Recently, Gustave Roussy, one of Europe's leading cancer treatment centers, announced the deployment of GrayOS, a sophisticated care orchestration platform developed by Gray. The implementation was revealed at the prestigious ESTRO conference, marking Gustave Roussy as the first European institute to utilize GrayOS in its radiation therapy department. This significant step aims to optimize treatment operations and streamline patient pathways.

In 2025, Gustave Roussy's radiation therapy department treated over 4,200 patients, facilitating more than 50,000 sessions thanks to a dedicated team of 150 healthcare professionals. The integration of GrayOS with existing systems such as MOSAIQ and DxCare is anticipated to bring dramatic improvements in treatment efficiency. The platform is designed to continuously optimize the scheduling of radiation therapy appointments, taking into account clinical parameters, resource availability, and operational guidelines.

Professor Éric Deutsch, Head of the Radiotherapy Department at Gustave Roussy, highlighted the increasing complexity of modern radiation therapy, noting how advancements not only enhance precision but also integrate various therapeutic modes. This complexity requires robust management tools, which existing resources struggled to accommodate. By choosing GrayOS, Gustave Roussy aims to evolve its operational framework to meet the growing demands of oncological treatment while allowing medical personnel to focus on delivering quality care to patients.

The deployment of GrayOS aligns with Gustave Roussy's 2030 Institutional Strategic Plan, which focuses on modernizing patient care pathways and fostering better interdisciplinary coordination. The plan includes equipping the facility with innovative tools necessary to navigate the dynamically evolving landscape of cancer treatment.

Early adopters of GrayOS have reported impressive outcomes, with treatment capacities increasing by 5 to 15% without additional resources. Furthermore, the time spent managing appointment coordination has plummeted by around 80%. These results stem from rigorous impact analyses conducted on institutions that have integrated the GrayOS platform into their operations, underscoring its potential to transform cancer care.

With the deployment of GrayOS, Gustave Roussy is poised to set new benchmarks in cancer treatment efficiency and patient satisfaction. This initiative not only reaffirms their commitment to adopting cutting-edge technologies but also enhances the overall quality of patient experiences as they navigate their treatment journeys.

In conclusion, the collaboration between Gustave Roussy and Gray signifies a promising advancement in oncology care delivery, offering a template for other institutions seeking to improve operational efficiency and patient care. As healthcare continues to evolve, the integration of innovative technologies like GrayOS will be paramount in addressing the complexities of modern cancer treatment.